You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – The US Fsood and Drug Administration today approved a new combination treatment from Genentech for HER2-positive metastatic breast cancer that may be administered to patients in their homes by a qualified healthcare professional.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.